You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histone Deacetylase Inhibitors

Showing 51 - 75 of 4,574
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)

Completed
  • Neoplasms
  • +14 more
  • San Antonio, Texas
    The START Center for Cancer Care
Apr 21, 2022

Small-cell Lung Cancer, Soft Tissue Sarcoma, Triple-negative Breast Cancer Trial in Canada, United States (Tinostamustine

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Tinostamustine (EDO-S101)
  • Los Angeles, California
  • +7 more
Dec 22, 2020

Prostate Adenocarcinoma Trial in Washington (Entinostat, Enzalutamide)

Terminated
  • Prostate Adenocarcinoma
  • Washington, District of Columbia
    George Washington University - Medical Faculty Associates
Jul 26, 2021

Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Sodium Valproate
  • +2 more
  • Saint Leonards, New South Wales, Australia
  • +8 more
Jan 22, 2023

Clinical Relevance of DNMT and HDAC Gene SNP on Response to

Completed
  • Myelodysplastic Syndrome
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Aug 11, 2020

    Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

    Recruiting
    • Hepatocellular Carcinoma (HCC)
    • Kaohsiung, Taiwan
    • +4 more
    Mar 14, 2023

    HR+ Metastatic Breast Cancer Patients Previously Treated With

    Recruiting
    • Breast Cancer
    • Beijing, Beijing, China
      The Fifth Medical Center of PLA General Hospital
    Mar 3, 2022

    Smoldering Multiple Myeloma Trial in Boston, Durham, Cleveland (Hiltonol, Citarinostat, Lenalidomide)

    Recruiting
    • Smoldering Multiple Myeloma
    • Boston, Massachusetts
    • +4 more
    Feb 22, 2021

    Multiple Myeloma Trial in Lille Cedex, Nantes, Tours (JNJ-2641585 / VELCADE / Dexamethasone)

    Completed
    • Multiple Myeloma
    • JNJ-2641585 / VELCADE / Dexamethasone
    • Lille Cedex, France
    • +2 more
    Jan 21, 2020

    Non Small Cell Lung Cancer Trial in United States (HBI-8000 in combination with pembrolizumab)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • HBI-8000 in combination with pembrolizumab
    • Goodyear, Arizona
    • +6 more
    Dec 5, 2022

    Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

    Recruiting
    • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
    • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
    • Guangzhou, Guangdong, China
      Cancer center of Sun Yat-sen University
    Jul 20, 2022

    Gastric Cancer, Histone Deacetylase Inhibitor Trial in Seoul (Vorinostat, capecitabine, and cisplatin)

    Completed
    • Gastric Cancer
    • Histone Deacetylase Inhibitor
    • Vorinostat, capecitabine, and cisplatin
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jan 6, 2020

    Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)

    Recruiting
    • Hemophilia B
    • Sodium valproate extended-release tablets
    • Beijing, China
      PLA General Hospital
    Jun 17, 2023

    Esophageal Squamous Cell Carcinoma Trial (Decitabine plus Penpulimab)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Decitabine plus Penpulimab
    • (no location specified)
    Feb 23, 2022

    Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Hodgkin Disease Trial in Chicago, Saint Louis (Romidepsin,

    Completed
    • Lymphoma, T-Cell, Cutaneous
    • +3 more
    • Chicago, Illinois
    • +1 more
    Nov 16, 2020

    Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)

    Active, not recruiting
    • Breast Adenocarcinoma
    • +9 more
    • Duarte, California
    • +4 more
    Jul 16, 2022

    Kabuki Syndrome Trial in Baltimore (Modified Atkins diet)

    Recruiting
    • Kabuki Syndrome
    • Modified Atkins diet
    • Baltimore, Maryland
      Kennedy Krieger Institute
    Nov 17, 2022

    Breast Cancer Trial (Tucidinostat, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Aug 7, 2021

    Bladder Cancer Trial in Chapel Hill, Philadelphia (Pembrolizumab, Entinostat)

    Recruiting
    • Bladder Cancer
    • Chapel Hill, North Carolina
    • +1 more
    Oct 10, 2022

    Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

    Not yet recruiting
    • Neoplasms
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 16, 2023

    Thrombocytopenia Trial (Chidamide, HD-DXM)

    Not yet recruiting
    • Thrombocytopenia
    • (no location specified)
    Jun 6, 2022

    Bladder Cancer Stage IV Trial in Guangzhou (Chidamide with tislelizumab)

    Recruiting
    • Bladder Cancer Stage IV
    • Chidamide with tislelizumab
    • Guangzhou, Guangdong, China
      Cancer Center, Sun Yat-sen University
    Oct 8, 2020

    Malignant Solid Tumour Trial in San Antonio (Hydroxychloroquine, Vorinostat)

    Active, not recruiting
    • Malignant Solid Tumour
    • San Antonio, Texas
      Cancer Therapy & Research Center University of Texas Health Scie
    Dec 13, 2021

    Uveal Melanoma Trial (Vorinostat)

    Withdrawn
    • Uveal Melanoma
    • (no location specified)
    Feb 4, 2020

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Biopsy
    • +9 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Nov 17, 2023